Jatin S. Gandhi, MBBS, MD, is an assistant professor in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine. A board-certified pathologist, Dr. Gandhi specializes in the review of genitourinary oncologic and bone-soft tissue pathology. He is a member of the Cell and Molecular Biology Research Program at Winship Cancer Institute.
Education
Dr. Gandhi received his MBBS from Indira Gandhi Medical College in Nagpur, India, and his MD from Seth GSMC and KEM Hospital in Mumbai, India. He completed his residency in anatomic pathology at the University of Tennessee in Memphis, Tennessee. He completed a genitourinary pathology fellowship at Memorial Sloan Kettering in New York, New York, and a bone-soft tissue pathology fellowship at the University of Washington in Seattle, Washington.
Titles & Roles
Assistant Professor, Department of Pathology and Laboratory Medicine
Emory University School of Medicine
Education & Training
Education
Fellowship, Bone-Soft Tissue, 2022
University of Washington Medical Center
Fellowship, Genitourinary, 2021
Memorial Sloan Kettering Cancer Center
Residency, Pathology-Anatomic, 2020
University Of Tennessee College of Medicine
Residency, Pathology, 2007
KEM Hospital and Seth GSMC, Mumbai, INDIA
Medical Education, MBBS, 2001
Indira Gandhi Medical College NAGPUR INDIA
Board Certifications
Anatomic Pathology
American Board of Pathology, 2020
Professional Memberships
Dr. Gandhi holds professional memberships with International Society of Bone and Soft Tissue Pathology, Genitourinary Pathology Society and College of American Pathologists. He was previously an ambassador for United States and Canadian Academy of Pathology.
Research
Dr. Gandhi's research is directed towards identification of morphologic, diagnostic, prognostic and predictive markers in genitourinary and bone-soft tissue malignancies. He is also interested in evaluating the role of artificial intelligence as a valuable tool in pathology.
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
